First Treatment Approved for Chronic Rhinosinusitis Without Nasal Polyps

(MedPage Today) -- The FDA expanded the approval of fluticasone propionate (Xhance) nasal spray for chronic rhinosinusitis to also include treatment of adults without nasal polyps, manufacturer Optinose announced on Friday. The drug-device combination...
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news